STERIS (STE) Revenue — Quarter Ended Mar 31, 2025
Revenue for the reported quarter increased compared with both the immediately preceding quarter and the same quarter one year earlier. The rate of increase was higher sequentially than it was on an annual basis.
Key takeaway
Quarter ended Mar 31, 2025 · FY2025 Q4
Revenue for the reported quarter increased compared with both the immediately preceding quarter and the same quarter one year earlier. The rate of increase was higher sequentially than it was on an annual basis.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$1.5B
Revenue reported for this quarter.
Quarter-over-quarter
+8.0%
Change from the immediately preceding quarter.
Year-over-year
+4.3%
Change from the comparable year-ago quarter.
Trailing four quarters
$5.5B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jun 30, 2024 | $1.3B | +8.1% |
| Sep 30, 2024 | $1.3B | +7.3% |
| Dec 31, 2024 | $1.4B | +5.6% |
| Mar 31, 2025 | $1.5B | +4.3% |
Revenue performance
The pace of revenue growth slowed compared with earlier quarters of the fiscal year, as the year-over-year increases in each preceding quarter were larger than in this quarter.
Quarterly comparison
Revenue rose from the prior quarter and also from the same quarter last year, with the sequential gain exceeding the annual gain.
What to watch
The deceleration in year-over-year revenue growth over the past several quarters may be a point to monitor.